Towards quadruple therapy for heart failure with reduced ejection fraction: DAPA-HF secondary analysis data

Towards quadruple therapy for heart failure with reduced ejection fraction: DAPA-HF secondary analysis data

Patients with heart failure with reduced ejection fraction (HFrEF), despite optimal evidence-based treatment, have a high residual risk of adverse outcomes. The favorable results of studies on cardiovascular safety and the effectiveness of sodium-glucose cotransporter 2 (SGLT2) inhibitors in patient...

Full description

Saved in:
Bibliographic Details
Main Authors: Zh. D. Kobalava, V. V. Medovchshikov, N. B. Yeshniyazov
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2020-06-01
Series:Российский кардиологический журнал
Subjects:
heart failure
reduced ejection fraction
type 2 diabetes
sglt2 inhibitors
dapagliflozin
guideline-recommended therapy
dapa-hf
sub-analysis
Online Access:https://russjcardiol.elpub.ru/jour/article/view/3870
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items